Showing results (441-450 of 464) with videos related to
Sort By:
Pageof 47
Cell Death & Disease|March 4, 2011
TGF-β induces TIAF1 self-aggregation via type II receptor-independent signaling that leads to generation of amyloid β plaques in Alzheimer's diseaseM-H Lee, S-R Lin, J-Y Chang, et al.American Journal of Medical Genetics. Part A|November 26, 2009
Genome-wide linkage scan of nonsyndromic orofacial clefting in 91 families of central European originElisabeth Mangold, Heiko Reutter, Stefanie Birnbaum, et al.Genomics|October 27, 1998
Human ARHGDIG, a GDP-dissociation inhibitor for Rho proteins: genomic structure, sequence, expression analysis, and mapping to chromosome 16p13.3C N Adra, A R Iyengar, F A Syed, et al.Nature Medicine|January 16, 2019
Translation control of the immune checkpoint in cancer and its therapeutic targetingYichen Xu, Mauro Poggio, Hyun Yong Jin, et al.Gastroenterology|July 13, 2000
Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized studyJ J Sung, S R Lin, J Y Ching, et al.Journal of Medicinal Chemistry|May 30, 2020
Design of Development Candidate eFT226, a First in Class Inhibitor of Eukaryotic Initiation Factor 4A RNA HelicaseJustin T Ernst, Peggy A Thompson, Christian Nilewski, et al.European Journal of Oral Sciences|February 4, 2010
IRF6 gene variants in Central European patients with non-syndromic cleft lip with or without cleft palateStefanie Birnbaum, Kerstin U Ludwig, Heiko Reutter, et al.Birth Defects Research. Part A, Clinical and Molecular Teratology|October 20, 2012
Resequencing of VAX1 in patients with nonsyndromic cleft lip with or without cleft palateEntessar Nasser, Elisabeth Mangold, Daniela C Tradowsky, et al.Journal of Medicinal Chemistry|May 3, 2002
Structure-based design of a parallel synthetic array directed toward the discovery of irreversible inhibitors of human rhinovirus 3C proteaseTheodore O Johnson, Ye Hua, Hiep T Luu, et al.Journal of Medicinal Chemistry|December 16, 1997
Viracept (nelfinavir mesylate, AG1343): a potent, orally bioavailable inhibitor of HIV-1 proteaseS W Kaldor, V J Kalish, J F Davies, et al.Pageof 47